Kambiz Yazdi
Stock Analyst at BTIG
(3.60)
# 2,182
Out of 5,032 analysts
85
Total ratings
48.4%
Success rate
8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABSI Absci | Reiterated: Buy | $16 | $10.27 | +55.79% | 8 | Oct 6, 2026 | |
| PRAX Praxis Precision Medicines | Rated: Buy | $810 → $826 | $280.14 | +194.85% | 16 | Oct 6, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $75 | $31.15 | +140.77% | 13 | Oct 1, 2026 | |
| KZIA Kazia Therapeutics | Reiterated: Buy | $40 | $9.26 | +331.97% | 5 | Sep 22, 2026 | |
| SION Sionna Therapeutics | Downgraded: Hold | n/a | $4.75 | - | 9 | Aug 10, 2026 | |
| VTVT vTv Therapeutics | Reiterated: Buy | $57 | $30.07 | +89.56% | 8 | Aug 6, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $24 | $10.73 | +123.67% | 6 | Aug 5, 2026 | |
| BME: PHM Pharma Mar, S.A. | Initiated Coverage: Buy | €121.00 | €70.30 | +72.12% | 1 | Apr 23, 2026 | |
| ARQT Arcutis Biotherapeutics | Reiterated: Buy | $31 | $23.92 | +29.60% | 6 | Jan 15, 2026 | |
| LQDA Liquidia | Reiterated: Buy | $27 → $31 | $25.91 | n/a | 6 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $13.59 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $3.17 | n/a | 1 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.61 | n/a | 1 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $14 | $0.9202 | n/a | 3 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.0005 | n/a | 1 | May 31, 2023 |
Absci
Oct 6, 2026
Reiterated: Buy
Price Target: $16
Current: $10.27
Upside: +55.79%
Praxis Precision Medicines
Oct 6, 2026
Rated: Buy
Price Target: $810 → $826
Current: $280.14
Upside: +194.85%
Rapport Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $75
Current: $31.15
Upside: +140.77%
Kazia Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $40
Current: $9.26
Upside: +331.97%
Sionna Therapeutics
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.75
Upside: -
vTv Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $57
Current: $30.07
Upside: +89.56%
Zevra Therapeutics
Aug 5, 2026
Reiterated: Buy
Price Target: $24
Current: $10.73
Upside: +123.67%
Pharma Mar, S.A.
Apr 23, 2026
Initiated Coverage: Buy
Price Target: €121.00
Current: €70.30
Upside: +72.12%
Arcutis Biotherapeutics
Jan 15, 2026
Reiterated: Buy
Price Target: $31
Current: $23.92
Upside: +29.60%
Liquidia
May 28, 2025
Reiterated: Buy
Price Target: $27 → $31
Current: $25.91
Upside: n/a
Mar 25, 2025
Initiated Coverage: Buy
Price Target: $23
Current: $13.59
Upside: n/a
Aug 28, 2024
Reiterated: Buy
Price Target: $15
Current: $3.17
Upside: n/a
Apr 11, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $1.61
Upside: n/a
Mar 7, 2024
Reiterated: Buy
Price Target: $15 → $14
Current: $0.9202
Upside: n/a
May 31, 2023
Upgraded: Buy
Price Target: $7
Current: $0.0005
Upside: n/a